Tagged With Johnson & Johnson

There's been a surge in health scares this October, with warnings issued for baby powder, Zantac, and frozen sausage patties


4 healthcare firms just agreed to a $260 million deal to settle key opioids cases ahead of a trial


Johnson & Johnson recalled a batch of baby powder after a test found asbestos. The company says the product is safe.



Talcum powder has unfairly become the 'poster child' for class-action lawsuits against Johnson & Johnson, its CFO says


Earnings season kick off this week. Here are 6 companies to watch — and what to look out for.


J&J slides after jury orders it to pay $8 billion in male breast-growth case



Johnson & Johnson ordered to pay Pennsylvania man $8 billion over claims he wasn't warned antipsychotic drug could make him grow breasts


Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial


J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company's market cap increased $15 billion in response.


10 CEOs that started in entry-level positions at the companies they now lead


J&J tumbles amid reports the DOJ launched a criminal investigation into whether it lied about its baby powder's cancer risks


Johnson & Johnson's net earnings dropped 14% in the first-quarter



Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential


Johnson & Johnson is being investigated by the SEC over fears its baby powder may cause cancer — here's how worried you should be


Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety


A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval



A fresh crop of promising drugs is poised to change the way depression is treated for the first time in decades. Here are the ones to watch in 2019.


Johnson & Johnson tumbles after report says it knew for decades that its baby powder contained asbestos


Almost $40 billion has been erased from Johnson & Johnson's market value, but JPMorgan says the selling is overdone


Canada warns talcum powder poses a risk of ovarian cancer after $4.69 billion product defect case